Literature DB >> 24897278

Pharmacogenetics of smoking: how far to the clinic?

Marieke Quaak1, Frederik J van Schooten, Constant P van Schayck.   

Abstract

Keywords:  clinical utility; pharmacogenetics; smoking cessation

Mesh：

Year:  2014        PMID： 24897278     DOI： 10.2217/pgs.14.34

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  2 in total

Review 1.  Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.

Authors:  Yadira X Perez-Paramo; Philip Lazarus
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-12-29       Impact factor: 4.481

2.  CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy.

Authors:  Juliana Rocha Santos; Paulo R X Tomaz; Jaqueline S Issa; Tânia O Abe; José E Krieger; Alexandre C Pereira; Paulo C J L Santos
Journal:  Front Genet       Date:  2015-02-27       Impact factor: 4.599
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.